Balvi has announced funding for an open-source vaccine initiative aimed at enabling global participation in vaccine manufacturing and research. This initiative seeks to democratize access to vaccine production and enhance the understanding of their medical properties. The project is part of a broader full-stack decentralized/accelerated (d/acc) roadmap that is now being implemented.